144
0001834021
XXXXXXXX
LIVE
0001650648
4D Molecular Therapeutics, Inc.
001-39782
5858 Horton Street
Suite 455
Emeryville
CA
94608
1-510-505-2680
David Kirn
Officer
Class A Common
Goldman Sachs & Co. LLC
200 West Street
New York
NY
10282
12930
300622.5
51703412
06/24/2024
NASD
Class A Common
02/10/2022
Acquired as compensation -- Stock Options
Issuer
N
4625
06/24/2024
Compensation -- Cashless exercise / same-day sale
Class A Common
12/11/2023
Acquired as compensation -- Stock Options
Issuer
N
8305
06/24/2024
Compensation -- Cashless exercise / same-day sale
Y
The sales of shares set forth herein are made in connection with a selling plan dated 3/21/2024, that is intended to comply with Rule 10b5-1(c).
06/24/2024
03/21/2024
Goldman Sachs & Co. LLC on behalf of David Kirn